Фильтр

Лекарственные препараты: обзор инвестиций и аналитика

Подотрасли: Лекарственные препараты - 248 (······)

Регионы: Москва - 22 (······) , Московская область - 33 (······) , Санкт-Петербург - 15 (······) , Калужская область - 10 (······) , Краснодарский край - 5 (······) , Кировская область - 5 (······) , Брянская область - 1 (······) , Мурманская область - 1 (······) , Еврейская автономная область - 1 (······) Показать все...

Стадии: Предпроектные проработки - 48 (······) , Планирование - 37 (······) , Проектирование - 19 (······) , Подготовка к строительству - 5 (······) , Модернизация - 24 (······) , Строительство - 1 (······)

Другие страны: Беларусь - 22 (······) , Казахстан - 20 (······) , Узбекистан - 29 (······) , Китай - 17 (······) , Кыргызстан - 6 (······) , Азербайджан - 2 (······) , Таджикистан - 1 (······)

Период: 2017 - 2034

Холдинги: 90

Проектов по фильтру: 248 (733,8 млрд руб.)

Новости холдингов отрасли

04.04.2025

Указом Президента Российской Федерации ООО «Фармирус» назначено управляющим 100%-м пакетом акций АО «Нижфарм».

Комментарий ПКР: это решение усиливает контроль над стратегически важными российскими предприятиями и имеет долгосрочные перспективы для развития фармацевтической отрасли России.

14.03.2025

···· ······················-··········: ······················ ·············· ········ ········ ···· ························································.·················································· ···························· ···································· ················ ········ ···· ························································.·············································· ···················· ···················································· ························································.·························································· ·················································· ·· ·················· ···· ························································.······················································ ·················· ································ ························ ···· ······················ ·············· ·················· ················ ···· ························································.······················································ ·················· ································ ·· ···· ························································.·············································· ···················· ·························································· ···· ······················-··········: ········································ ········ ······ ·············· ·········· ················ ·· ···················· ·············· ························ ················ ···· ·········· ·· ························ ················ ·················· ······················ ···················· ························ ··························

22.10.2024

···· ······················-··········: ························ ························································.···················································· ···················································· ·················· ········ ·········· ·················· ················ ···· ························································.························································ ························ ······································ ···················· ································ ·········· ·· ································ ······················ ·· ·········································· ···· ······················-··········: ·········································· ········ ························ ···· ························································.························································ ························ ···································· ·················· ······ ···· ························································.···················································· ···················································· ·········· ······················ ···· ································ ············ ·············· ············ ·········· ·········· ···························· ·········· ······ ···························· ·············· ·· ···················· ·············· ···· ·········· ·························· ······························

28.06.2023

······················ ·················· ············ ···· ···················· ·························· ···································· ·· ···························· ···· ························································.····························-··········-···························· ························ ················ ······ ·········· ·········· ·· ···· ························································.·················································································· ·········· ···· ························································.·········································································· ················ ································ ···· ······················ ························ ······ ························ ························ ·· ·············· ·· ················ ·················· ···· ·· ········ ········ ·················· ······ ·········· ·············· ·· ···················· ······················ ············ ···· ·········· ···················· ·················· ·· ······················ ···························· ········ ················ ······ ························································.·············································································· ················ ···· ·············· ················ ···· ························································.····························-··········-················································

28.02.2023

········ ·············· ········ ········ ················ ················ ···· ························································.·············································· ························ ···· ························································.············································································ ·········· ···················· ·········· ·········· ·· ···· ························································.························································ ······················ ······ ······················ ·················· ······························ ·· ···· ························································.······································-·························· ·················· ···························· ······ ········ ········ ·· ············ ·············· ···· ························································.·································································· ·········· ········ ···················· ·························· ···················· ···· ························································.················································································ ···························· ········ ···· ························································.························································ ···················· ·················· ························································.························································ ···················· ···················· ·· ············ ················ ···· ························································.············································································

03.10.2022

01.09.2022

········ ················-··················-·················· ························································.···························································································· ·············· ···················· ·········· ········ ·········· ························ ···· ························································.······································································ ·· ························ ·················· ·············· ················ ·············· ·············· ········ ·· ················ ············ ·········· ·········· ················ ·· ·············· ···· ·············· ·· ·············· ········ ········ ······················ ·············· ···· ··········-···· ···························· ················ ·················································· ········ ······ ························································.···································································· ················ ·· ············ ················ ···· ························································.····················································································································

29.08.2022

·································· ·············· ···· ························································.······································-···························· ······················ ·············· ·· ···· ·············· ·············· ······················ ·············· ········ ·········· ················ ·········· ······························ ················ ······················ ······ ······································ ············································ ···························· ········ ······················ ···················· ···· ························································.······································-···························· ························ ·· ········ ·················· ················ ········ ······ ················ ································

21.07.2022

········ ···················· ················ ·········· ·············· ···· ························································.·················································· ······························ ······························································ ······ ······················ ························ ················ ················ ················ ···· ································ ·············· ·· ·········· ······ ······ ···················· ···························· ········ ············ ·········· ·············· ···· ························································.····························································································

04.02.2022

································ ·············· ···· ························································.·································································· ············ ············ ···· ·············· ························ ············ ·········· ···················· ················ ········ ···· ························································.·············································································· ···· ············ ········ ················ ················ ·············· ········ ·················· ···· ························································.············································································ ············ ···· ·········· ············ ················ ········ ·· ············ ·········· ···· ························································.····································-········································ ·· ················ ············ ············ ·············· ···················· ················ ·· ······································ ···························· ········ ···· ························································.············································································ ················ ·· ············ ················ ···· ························································.·································································· ·· ················ ································

Структура инвестиций

Инвестиции по регионам

Инвестиции по отраслям

Инвесторы и соинвесторы

Проектировщики и подрядчики

Динамика инвестиций

Приостановка и отмена

Инвестиции по годам

Иностранные инвестиции

Площадь объектов

ОЭЗ, ТОР, Индустриальные парки

Все проекты

* По умолчанию фильтр учитывает все стадии проектов кроме «приостановлен».

* По умолчанию фильтры выстроены от самого раннего срока начала строительства проекта по самый поздний срок предполагаемого ввода в эксплуатацию

* По умолчанию фильтры учитывают: все стадии проектов, кроме "Отменен"; от самого раннего срока начала строительства проекта по самый поздний срок прогнозного ввода в эксплуатацию ** В таблице выводится до 150 холдингов-участников проектов в отрасли

* По умолчанию фильтры учитывают: только активные стадии проектов; от самого раннего срока начала строительства проекта по самый поздний срок предполагаемого ввода в эксплуатацию,** По умолчанию выводится ТОП инвесторов. Для выбора остальных категорий воспользуйтесь легендой слева от графика

Структура инвестиций в иностранной собственности без российских бенефициаров в отрасли "Лекарственные препараты" (Данные обновляются)

* По умолчанию фильтры учитывают: только активные стадии проектов; от самого раннего срока начала строительства проекта по самый поздний срок предполагаемого ввода в эксплуатацию,** По умолчанию выводится ТОП генпроектировщиков. Для выбора остальных категорий воспользуйтесь легендой слева от графика

* По умолчанию фильтры учитывают: только активные стадии проектов; от самого раннего срока начала строительства проекта по самый поздний срок предполагаемого ввода в эксплуатацию,** По умолчанию выводится ТОП генподрядчиков. Для выбора остальных категорий воспользуйтесь легендой слева от графика

Структура инвестиций Инвестиции по регионам Инвестиции по отраслям Инвесторы и соинвесторы Проектировщики и подрядчики Динамика инвестиций Приостановка и отмена Инвестиции по годам Иностранные инвестиции Площадь объектов ОЭЗ, ТОР, Индустриальные парки Все проекты

Необходимо зарегистрироваться!

Лекарственные препараты: обзор инвестиций и аналитика

Инвестиции в проекты по годам в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по подотраслям в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по отраслям в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по регионам в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по ФО в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по отраслям в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по федеральным округам в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по регионам в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по подотраслям в отрасли "Лекарственные препараты" (Данные обновляются)

Крупные холдинги-инвесторы проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Крупные компании-инвесторы проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Генеральные проектировщики в отрасли "Лекарственные препараты" (Данные обновляются)

Генеральные подрядчики в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по стадиям в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по видам собственности в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по видам строительства в отрасли "Лекарственные препараты" (Данные обновляются)

Топ крупнейших групп проектов в отрасли "Лекарственные препараты"

Проекты в отрасли "Лекарственные препараты"

Изменение стадий инвестпроектов в отрасли "Лекарственные препараты"

Структура инвестиций по отраслям по годам в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по подотраслям по годам в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по ФО по годам в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по регионам по годам в отрасли "Лекарственные препараты" (Данные обновляются)

Ввод в эксплуатацию (и прогноз ввода) проектов по годам в отрасли "Лекарственные препараты" (Данные обновляются)

Структура ролей холдинга в проектах в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по стадиям в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по видам собственности в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по размерности проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Инвестиционная активность за 12 месяцев в отрасли "Лекарственные препараты" (Данные обновляются)

Количество и стоимость проектов на активной стадии (без приостановленных) в отрасли "Лекарственные препараты" (Данные обновляются)

Активные и реализованные объекты (без приостановленных и отмененных) в отрасли "Лекарственные препараты" (Данные обновляются)

Динамика добавления новых проектов на платформу в отрасли "Лекарственные препараты" (Данные обновляются)

Динамика добавления новых проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Динамика ввода проектов в эксплуатацию в отрасли "Лекарственные препараты" (Данные обновляются)

Динамика выхода проектов из приостановки в отрасли "Лекарственные препараты" (Данные обновляются)

Топ холдингов-инвесторов проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Топ компаний-инвесторов проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Крупные инвесторы проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций в иностранной собственности без российских бенефициаров в отрасли "Лекарственные препараты" (Данные обновляются)

Российские инвестиции в другие страны в отрасли "Лекарственные препараты" (Данные обновляются)

Структура иностранных инвестиций в отрасли "Лекарственные препараты" (Данные обновляются)

Российские генпроектировщики в других странах в отрасли "Лекарственные препараты" (Данные обновляются)

Российские генподрядчики в других странах в отрасли "Лекарственные препараты" (Данные обновляются)

Квартирография в отрасли "Лекарственные препараты" (Данные обновляются)

Совместные инвестиции в отрасли "Лекарственные препараты" (Данные обновляются)

Основные холдинги-инвесторы в отрасли "Лекарственные препараты" (Данные обновляются)

Основные холдинги-инвесторы в отрасли "Лекарственные препараты" (Данные обновляются)

Динамика выручки холдингов инвесторов отрасли в отрасли "Лекарственные препараты" (Данные обновляются)

Объем инвестиций в отрасли "Лекарственные препараты" (Данные обновляются)

Холдинги в отрасли "Лекарственные препараты" (Данные обновляются)

Новых проектов за последний квартал в отрасли "Лекарственные препараты" (Данные обновляются)

Период в отрасли "Лекарственные препараты" (Данные обновляются)

Всего проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Площадь объектов по отраслям в отрасли "Лекарственные препараты" (Данные обновляются)

Площадь объектов по подотраслям в отрасли "Лекарственные препараты" (Данные обновляются)

Площадь объектов по ФО в отрасли "Лекарственные препараты" (Данные обновляются)

Топ генпроектировщиков проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Генеральные проектировщики в отрасли "Лекарственные препараты" (Данные обновляются)

Топ генподрядчиков проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Генеральные подрядчики в отрасли "Лекарственные препараты" (Данные обновляются)

Топ площадок, на которых реализуются проекты в отрасли "Лекарственные препараты" (Данные обновляются)

Площадки, на которых реализуются проекты в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по типам площадок в отрасли "Лекарственные препараты" (Данные обновляются)

Классификация этажности в отрасли "Лекарственные препараты" (Данные обновляются)

Классификация этажности ввод по годам в отрасли "Лекарственные препараты" (Данные обновляются)

Классификация этажности в отрасли "Лекарственные препараты" (Данные обновляются)

Протяжённость труб по годам по ФО в отрасли "Лекарственные препараты" (Данные обновляются)

Протяженность труб и классификация диаметров в отрасли "Лекарственные препараты" (Данные обновляются)

Протяженность труб и классификация диаметров: ввод по годам в отрасли "Лекарственные препараты" (Данные обновляются)

Топ инвесторов и соинвесторов проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Инвесторы и соинвесторы в отрасли "Лекарственные препараты" (Данные обновляются)

Топ генеральных проектировщиков проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Генеральные проектировщики в отрасли "Лекарственные препараты" (Данные обновляются)

Топ генеральных подрядчиков проектов в отрасли "Лекарственные препараты" (Данные обновляются)

Генеральные подрядчики в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по странам в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по ФО в отрасли "Лекарственные препараты" (Данные обновляются)

Структура инвестиций по регионам РФ в отрасли "Лекарственные препараты" (Данные обновляются)